These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 25751430)
1. Cognitive functions in first-episode depression and recurrent depressive disorder. Talarowska M; Zajączkowska M; Gałecki P Psychiatr Danub; 2015 Mar; 27(1):38-43. PubMed ID: 25751430 [TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment in remitted and non-remitted depressive patients: A follow-up comparison between first and recurrent episodes. Roca M; López-Navarro E; Monzón S; Vives M; García-Toro M; García-Campayo J; Harrison J; Gili M Eur Neuropsychopharmacol; 2015 Nov; 25(11):1991-8. PubMed ID: 26293584 [TBL] [Abstract][Full Text] [Related]
3. The relationship of Theory of Mind with symptoms and cognitive impairment in bipolar disorder: a prospective study. Ioannidi N; Konstantakopoulos G; Sakkas D; Oulis P Psychiatriki; 2015; 26(1):17-27. PubMed ID: 25880380 [TBL] [Abstract][Full Text] [Related]
4. [Emotional and language prosody and working memory in patients with depression]. Talarowska M; Zajączkowska M; Gałecki P Pol Merkur Lekarski; 2015 May; 38(227):269-72. PubMed ID: 26039021 [TBL] [Abstract][Full Text] [Related]
5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
6. Nitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorder. Talarowska M; Gałecki P; Maes M; Orzechowska A; Chamielec M; Bartosz G; Kowalczyk E Neurosci Lett; 2012 Feb; 510(2):127-31. PubMed ID: 22273980 [TBL] [Abstract][Full Text] [Related]
7. The role of MMP genes in recurrent depressive disorders and cognitive functions. Bobińska K; Szemraj J; Gałecki P; Talarowska M Acta Neuropsychiatr; 2016 Aug; 28(4):221-31. PubMed ID: 26856768 [TBL] [Abstract][Full Text] [Related]
8. Thiol protein groups correlate with cognitive impairment in patients with recurrent depressive disorder. Gałecki P; Talarowska M; Bobińska K; Kowalczyk E; Gałecka E; Lewiński A Neuro Endocrinol Lett; 2013; 34(8):780-6. PubMed ID: 24522026 [TBL] [Abstract][Full Text] [Related]
9. Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study. Xu G; Lin K; Rao D; Dang Y; Ouyang H; Guo Y; Ma J; Chen J J Affect Disord; 2012 Feb; 136(3):328-39. PubMed ID: 22169253 [TBL] [Abstract][Full Text] [Related]
10. Total antioxidant status correlates with cognitive impairment in patients with recurrent depressive disorder. Talarowska M; Gałecki P; Maes M; Bobińska K; Kowalczyk E Neurochem Res; 2012 Aug; 37(8):1761-7. PubMed ID: 22562440 [TBL] [Abstract][Full Text] [Related]
11. Manganese superoxide dismutase gene expression and cognitive functions in recurrent depressive disorder. Talarowska M; Orzechowska A; Szemraj J; Su KP; Maes M; Gałecki P Neuropsychobiology; 2014; 70(1):23-8. PubMed ID: 25171019 [TBL] [Abstract][Full Text] [Related]
12. Cognitive deficits in the euthymic phase of unipolar depression. Preiss M; Kucerova H; Lukavsky J; Stepankova H; Sos P; Kawaciukova R Psychiatry Res; 2009 Oct; 169(3):235-9. PubMed ID: 19765829 [TBL] [Abstract][Full Text] [Related]
13. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls]. Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195 [TBL] [Abstract][Full Text] [Related]
14. [Influence of attention on an auditory-verbal learning test in schizophrenic patients]. Huguelet P; Nicastro R; Zanello A Encephale; 2002; 28(4):291-7. PubMed ID: 12232538 [TBL] [Abstract][Full Text] [Related]
15. Cognitive deficits in the remitted state of unipolar depressive disorder. Hasselbalch BJ; Knorr U; Hasselbalch SG; Gade A; Kessing LV Neuropsychology; 2012 Sep; 26(5):642-651. PubMed ID: 22823136 [TBL] [Abstract][Full Text] [Related]
16. Cognitive function after clinical remission in patients with melancholic and non-melancholic depression: a 6 month follow-up study. Roca M; Monzón S; Vives M; López-Navarro E; Garcia-Toro M; Vicens C; Garcia-Campayo J; Harrison J; Gili M J Affect Disord; 2015 Jan; 171():85-92. PubMed ID: 25299439 [TBL] [Abstract][Full Text] [Related]
17. [Markers of cognitive vulnerability in major depression]. Sárosi A; Balogh G; Székely A; Sasvári M; Faludi G Neuropsychopharmacol Hung; 2007 Dec; 9(4):183-8. PubMed ID: 18510262 [TBL] [Abstract][Full Text] [Related]
18. Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder. Talarowska M; Gałecki P; Maes M; Gardner A; Chamielec M; Orzechowska A; Bobińska K; Kowalczyk E Mol Biol Rep; 2012 May; 39(5):5359-66. PubMed ID: 22170602 [TBL] [Abstract][Full Text] [Related]
19. [Deficits in memory retrieval: an argument in favor of frontal subcortical dysfunction in depression]. Fossati P; Deweer B; Raoux N; Allilaire JF Encephale; 1995; 21(4):295-305. PubMed ID: 7588169 [TBL] [Abstract][Full Text] [Related]
20. Is there a link between TNF gene expression and cognitive deficits in depression? Bobińska K; Gałecka E; Szemraj J; Gałecki P; Talarowska M Acta Biochim Pol; 2017; 64(1):65-73. PubMed ID: 27991935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]